Drug Interaction Report

Insulin Aspart, Recombinant and Acarbose: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Acarbose

Prandase® Precose Precose®
+

Insulin Aspart, Recombinant

Fiasp Kirsty Merilog NovoLog
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 134 documented Insulin Aspart, Recombinant interactions, 95 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Acarbose and insulin aspart both lower blood sugar, so together they raise the risk of hypoglycemia; your team may lower your insulin dose and watch your sugars, and you should treat any lows with glucose tablets rather than table sugar.

You've been prescribed acarbose (a diabetes pill that slows how you digest sugar) along with insulin aspart (a fast-acting mealtime insulin). Both lower your blood sugar, so using them together can push it down more than either one alone. That means a higher chance of low blood sugar (hypoglycemia), which can cause shakiness, sweating, confusion, or feeling faint.

The good news is this is very manageable. Your care team may lower your insulin dose and check your sugars a bit more closely while your body adjusts. One important tip: if you have a low while taking acarbose, treat it with glucose tablets or gel rather than table sugar or juice, since acarbose can slow how quickly regular sugar works.

Effect: Additive pharmacodynamic hypoglycemia when acarbose (alpha-glucosidase inhibitor) is combined with insulin aspart. Both lower blood glucose through different mechanisms, producing an additive glucose-lowering effect. Neither agent is enzymatically dependent on the other; this is a PD interaction, not PK.

  • Direction: Increased hypoglycemia risk (enhanced combined effect).
  • Onset: Unspecified.
  • Evidence: Theoretical; severity rated major.
  • Management: Insulin dose may need reduction and individualization; increase glucose monitoring. Counsel that acarbose delays sucrose/polysaccharide breakdown, so treat hypoglycemia with oral glucose (dextrose), not sucrose.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of hypoglycemia

Interaction Deep Dive

When oral antidiabetic drugs are taken together with insulin1 or pramlintide2, glucose metabolism can be affected, potentially raising the likelihood of hypoglycemia. A reduction in the insulin dose may be required when it is combined with oral antidiabetic agents3.

Why it happens (mechanism)

Altered glucose metabolism; additive hypoglycemia

How to manage this interaction

This combination is often used intentionally to control diabetes, so the goal is to keep the benefit while lowering the risk of a blood sugar drop.

  • Keep taking both exactly as prescribed unless your care team tells you otherwise.
  • Your insulin dose may need to be adjusted and individualized by your care team, and they may monitor your blood sugars more closely at first.
  • Learn the signs of low blood sugar (shaky, sweaty, dizzy, confused) and check your levels as advised.
  • Treat lows with glucose tablets or gel, because acarbose can slow how fast regular sugar or juice raises your blood sugar.

Raise any frequent lows with your pharmacist or prescriber so your plan can be fine-tuned.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Insulin Aspart, Recombinant and Acarbose together?

Acarbose and insulin aspart both lower blood sugar, so together they raise the risk of hypoglycemia; your team may lower your insulin dose and watch your sugars, and you should treat any lows with glucose tablets rather than table sugar. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Insulin Aspart, Recombinant and Acarbose interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Insulin Aspart, Recombinant and Acarbose interaction managed?

This combination is often used intentionally to control diabetes, so the goal is to keep the benefit while lowering the risk of a blood sugar drop. Keep taking both exactly as prescribed unless your care team tells you otherwise. Your insulin dose may need to be adjusted and individualized by your care team, and they may monitor your blood sugars more closely at first. Learn the signs of low blood… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Insulin Aspart, Recombinant or Acarbose need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: Tresiba subcutaneous injection solution, insulin degludec subcutaneous injection solution. Novo Nordisk A/S (per EMA), Bagsvaerd, Denmark, 2013. DailyMed
  2. Product Information: SYMLIN(R) subcutaneous injection, pramlintide acetate subcutaneous injection. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2016. DailyMed
  3. Product Information: GLYXAMBI(R) oral tablets, empagliflozin linagliptin oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per manufacturer), Ridgefield, CT, 2019. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.